News

NDRI Welcomes Richard D. Hasz, Jr. to Leadership Board

NDRI Welcomes Richard D. Hasz, Jr. to Leadership Board

NDRI Elects Richard D. Hasz, Jr. to the Board of Directors

The National Disease Research Interchange (NDRI) is proud to announce the election of Richard D. Hasz, Jr., MFS, CPTC, to its Board of Directors. As the President and CEO of the Gift of Life Donor Program, Hasz is recognized as a leader in the organ procurement field in the United States. He will serve a three-year term, beginning immediately, harnessing his extensive experience in organ and tissue donation.

Welcoming a Respected Leader

Bill Leinweber, President and CEO of NDRI, expressed his enthusiasm, stating, "It is a privilege to welcome Rick as a member of the NDRI Board of Directors. He is a respected member of the OPO community, bringing over 30 years of life-saving endeavors in his industry. Rick's contributions to various NIH-supported research initiatives are commendable, and we anticipate great collaboration with him in his new role."

Hasz’s Notable Career and Contributions

Joining Gift of Life in 1993, Hasz has garnered national respect for his knowledge and capabilities in organ donation and transplantation. As the organization's President and CEO since 2022, he has been pivotal in driving initiatives that ensure exceptional donation processes and transplant outcomes across the country. His approach has involved establishing significant partnerships both within the Gift of Life organization and with healthcare leaders nationwide.

Commitment to Research and Innovation

Reflecting on his new role, Hasz stated, "Gift of Life has championed medical research from the start of our program 50 years ago, and we have proudly partnered with NDRI since it began in 1980. This collaboration has allowed us to present donors and their families with the chance to create lasting legacies through significant medical research that benefits countless individuals. As a board member, I am eager to further advance NDRI’s essential research missions."

Engagement in National Organizations

Hasz’s involvement extends beyond his executive role; he actively participates in numerous national committees and organizations focused on donation and transplantation. His board memberships include prominent groups such as the Organ Donation and Transplantation Alliance, and the Association for Organ Procurement Organizations. Additionally, he contributes to the OPTN Membership and Professional Standards Committee and serves as a National Faculty Member for the CMS/HRSA End Stage Renal Disease Treatment Choices Learning Collaborative.

Support from NDRI Leadership

Dr. Mary J.C. Hendrix, Ph.D., Chair of the NDRI Board and President of Shepherd University, has also conveyed her support for Hasz’s appointment, stating, "We are thrilled to welcome Rick to the NDRI Board of Directors. His deep understanding of organ and tissue donation will enhance our mission and benefit researchers, donors, and sites across the nation."

About NDRI

NDRI stands as the nation’s leading source for human tissues, cells, and organs for scientific research. As a not-for-profit organization established in 1980 and funded by NIH, as well as public and private foundations, NDRI operates 24/7. It collaborates with over 130 tissue source sites, including organ procurement organizations, tissue banks, eye banks, and hospitals. By bridging the gap between procurement sources and researchers, NDRI supports groundbreaking discoveries aimed at advancing treatments and cures for human diseases.

Frequently Asked Questions

Who is Richard D. Hasz, Jr.?

Richard D. Hasz, Jr. is the President and CEO of the Gift of Life Donor Program and has been elected to the NDRI Board of Directors.

What is NDRI?

NDRI is the leading source of human tissues, cells, and organs for scientific research in the U.S., established to support medical research and innovation.

What is Hasz’s experience in the industry?

Hasz brings over 30 years of experience in organ donation and transplantation, recognized for his leadership in the field.

What organizations is Hasz involved with?

Hasz serves on various boards including the Organ Donation and Transplantation Alliance and the Association for Organ Procurement Organizations.

How does NDRI support research?

NDRI connects procurement sources with researchers to facilitate groundbreaking medical innovations aimed at treating human diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Atomic Mobile's Global IoT Game Changer in Connectivity

Updated Category News Views 59

Atomic Orbit Unlocks Global Connectivity Think about the hassle businesses face globally when devices drop off the grid. It's like losing a lifeline. Atomic Mobile, outta Spring Lake, decided enough's enough and dropped their latest brainchild on the world — Atomic Orbit. This bad boy is turning heads because it's not clinging to a single carrier. Instead, it's dancing...

Continue Reading
JDEnergy Shines as BNEF Tier 1 Leader Yet Again

Updated Category News Views 51

JDEnergy: A Persistent Force in Energy Storage Let's get straight to the point: JDEnergy is hitting the mark once again. For the seventh consecutive time, they've nailed a spot on BloombergNEF's Tier 1 Energy Storage Manufacturer list. Now, this ain't no small feat, folks. It’s like being a heavyweight champ keeping the title even as the competition intensifies and the...

Continue Reading
LUX Infusion Expands in Nebraska with New Acquisitions

Updated Category News Views 108

Strategic Expansion: LUX Infusion's Bold Move When it comes to healthcare, it's often about pulling the right strings at the right time, and today, LUX Infusion's got their timing spot on. They've swooped in with a savvy acquisition, taking over two key specialty infusion centers in Lincoln and Omaha. This isn't just a pencil-pusher's cynical corporate move; it's a push...

Continue Reading
Edible Oils: Market Growth, Trends, and Investments

Updated Category News Views 90

Riding the Edible Oil Wave The edible oils market seems to be gearing up for a steady rise. Folks, the numbers are speaking loud and clear. We're looking at the market booming from USD 277.74 billion in 2026 to a hefty USD 351.08 billion in 2031. According to MarketsandMarkets™, a compound annual growth rate (CAGR) of 4.8% is on the cards. Now, if that doesn't get the...

Continue Reading
SOPHiA GENETICS' Q3 2026: Revenue Growth & Challenges

Updated Category News Views 36

Unpacking SOPHiA GENETICS' Third Quarter Figures Let's cut through the jargon and get straight to the brass tacks. SOPHiA GENETICS (NASDAQ:SOPH) just posted their third quarter numbers for 2026, and it’s a mixed bag, my friends. Sure, they boasted a 25% bump in revenue, hitting $24.3 million, but the devil's in the details—net losses nudged up to $20.3 million, not...

Continue Reading
Yuhang's Innovative Tech: Journalists Get A Front Row Seat

Updated Category News Views 223

A Sneak Peek into Yuhang's Technological Leap Imagine strolling through a place where technology and nature coexist in harmony. That's exactly what journalists from around the globe got to experience during their recent jaunt to Yuhang District in Hangzhou. We're talking about reps from South Korea, Turkey, the U.S., and even Cuba getting a firsthand look at Yuhang's...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 76

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading
Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Consumer Electronics Boom: Profits Soar Till 2035

Updated Category News Views 33

Riding the Electronics Tsunami The consumer electronics sector isn't just catching a wave; it's barreling through a technological tsunami. Projected to leap from USD 1100.87 billion in 2026 to USD 2825.55 billion by 2035, we're talking a whopping 11.04% CAGR. It's driven by none other than the smartphone frenzy, intelligent computing advances, and the almighty connected...

Continue Reading
AEYE Health's AI Triumph: Preventing Blindness on the Move

Updated Category News Views 120

Making Diabetic Eye Exams Effortless Folks, the healthcare landscape just got a jolt from an unexpected corner. AEYE Health, with its AI wizardry, snagged the 2026 Prix Galien USA Award. This ain't your run-of-the-mill blue ribbon from a county fair; it's a heavyweight title in the world of medical innovation. The harbinger of this change? AEYE-DS, an AI-packed gadget...

Continue Reading

Top 5 Most Recently Viewed Articles

High Wire Networks Achieves Significant Growth in Profits

Updated Category News Views 164

High Wire Networks Reports Impressive Gross Profit Growth High Wire Networks, Inc. (OTCQB: HWNI), known globally as a premier provider of managed cybersecurity services, announced an exciting milestone: a remarkable 10% boost in gross profit during the last 90 days. This significant growth is attributed to a combination of strategic initiatives, operational focus, and a...

Continue Reading
AffableBPM Joins Creative Destruction Lab to Transform Healthcare

Updated Category News Views 191

AffableBPM Accepted into Prestigious Creative Destruction Lab Program AffableBPM, a key player in automating back-office processes for healthcare, has proudly announced its acceptance into the renowned Creative Destruction Lab (CDL) program. This exciting development positions the company to join the CDL-Seattle’s Computational Health Stream, a part of the Foster School...

Continue Reading
Understanding Short Interest Dynamics for Everest Group

Updated Category News Views 140

Analyzing Short Interest Trends in Everest Group Everest Group recently reported an increase in its short percent of float, which has risen to an impressive 28.07%. Currently, there are approximately 799 thousand shares sold short, accounting for 2.92% of the total shares available for trading. Given the current trading volume, it would take traders an average of 1.73...

Continue Reading
Class Action Filed Against Integral Ad Science - Investor Alert

Updated Category News Views 128

Class Action Lawsuit Against Integral Ad Science Holding Corp. Pomerantz LLP has announced the initiation of a class action lawsuit against Integral Ad Science Holding Corp. (NASDAQ: IAS). This legal action arises from various concerns regarding the company’s business practices and potential securities fraud. Investors who believe they may have suffered losses due to...

Continue Reading
Challenges Ahead for Tesla in Autonomous Vehicle Leadership

Updated Category News Views 220

Bernstein’s Cautious Outlook on Tesla Bernstein SocGen Group recently reaffirmed its Underperform rating on Tesla (NASDAQ: TSLA) with a price target of $120. The firm analyzed Tesla's third-quarter delivery numbers, reporting approximately 463,000 vehicles delivered. While this figure aligns with sell-side consensus expectations, it fell slightly short of the projected...

Continue Reading